Molecular Mechanism of SAHA on Regulation of Autophagic Cell Death in Tamoxifen-Resistant MCF-7 Breast Cancer Cells
Objective: Tamoxifen is currently used for the treatment of estrogen receptor-positive breast cancer patients, but acquired resistance to tamoxifen is a critical problem in breast cancer therapy.Suberoylanilide hydroxamic acid (SAHA) is a prototype of the newly developed HDAC inhibitor.The aim of th...
Uloženo v:
Hlavní autoři: | , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | angličtina |
Vydáno: |
2012
|
On-line přístup: | https://doi.org/10.7150/ijms.5011 https://www.medsci.org/v09p0881.pdf |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|